These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7744588)

  • 1. Clinical characteristics of second primary tumors following breast cancer.
    Robinson E; Adler Z; Nasrallah S; Rennert G; Neugut AI
    Isr J Med Sci; 1995; 31(2-3):169-71. PubMed ID: 7744588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal carcinomas occurring in breast cancer patients.
    Pappo I; Stahl-Kent V; Sandbank J; Karni T; Wasserman I; Halevy A
    Breast J; 2006; 12(5):437-41. PubMed ID: 16958962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary malignancies associated with primary female breast cancer: a review of the Danbury Hospital experience.
    La Francis IE; Cooper RB
    Conn Med; 1992 Aug; 56(8):411-4. PubMed ID: 1526142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
    Yi SZ; Zhang DC; Wang YG; Sun KL
    Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the contralateral breast in patients with ipsilateral breast carcinoma: the role of mammography.
    Muttarak M; Pojchamarnwiputh S; Padungchaichote W; Chaiwun B
    Singapore Med J; 2002 May; 43(5):229-33. PubMed ID: 12188073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
    Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer in multiple primary malignant neoplasms, epidemiological and clinical analysis].
    Wang C; Zhao P; Bai X; Wang H; Bai Y
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1229-31. PubMed ID: 12425798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of bilateral breast carcinoma: long-term results.
    Goksel HA; Yagmurdur MC; Karakayali H; Moray G; Demirhan B; Isiklar I; Bilgin N; Haberal M
    Int Surg; 2004; 89(3):166-71. PubMed ID: 15521255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral breast cancer: factors associated with stage and size at presentation.
    Mertens WC; Hilbert V; Makari-Judson G
    Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the early detection of metachronous contralateral breast cancer.
    Ciatto S; Miccinesi G; Zappa M
    Eur J Cancer; 2004 Jul; 40(10):1496-501. PubMed ID: 15196532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer?
    Ozaki S; Tozaki M; Fukuma E; Kawano N; Suzuki T; Yamashiro N; Sakamoto M; Tsuruhara T; Sakamoto N; Higa K; Abe S; Ogawa T; Tsunoda Y; Nobuhito K
    Breast Cancer; 2008; 15(2):169-74. PubMed ID: 18317885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
    Abdalla I; Thisted RA; Heimann R
    Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
    Andersson M; Jensen MB; Engholm G; Henrik Storm H
    Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral breast cancer.
    Gogas J; Markopoulos C; Skandalakis P; Gogas H
    Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple primary tumors in men with breast cancer diagnoses: a SEER database review.
    Wernberg JA; Yap J; Murekeyisoni C; Mashtare T; Wilding GE; Kulkarni SA
    J Surg Oncol; 2009 Jan; 99(1):16-9. PubMed ID: 18937232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
    Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
    Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.
    Weinmann S; Taplin SH; Gilbert J; Beverly RK; Geiger AM; Yood MU; Mouchawar J; Manos MM; Zapka JG; Westbrook E; Barlow WE
    J Natl Cancer Inst Monogr; 2005; (35):33-8. PubMed ID: 16287883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.